Invention Grant
- Patent Title: Method of treating heart failure with preserved ejection fraction by administering milrinone
-
Application No.: US16700237Application Date: 2019-12-02
-
Publication No.: US11291660B2Publication Date: 2022-04-05
- Inventor: David Kaye
- Applicant: Baker Heart and Diabetes Institute
- Applicant Address: AU Melbourne
- Assignee: Baker Heart and Diabetes Institute
- Current Assignee: Baker Heart and Diabetes Institute
- Current Assignee Address: AU Melbourne
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: AU2014905194 20141222
- Main IPC: A61K31/444
- IPC: A61K31/444 ; A61K9/20 ; A61K9/28 ; A61K9/48 ; A61K9/50
Abstract:
The present invention relates to methods of treating subjects having heart failure with preserved ejection fraction (HFpEF) with a sustained-delivery formulation of cardiotonic 5-(pyridinyl)-2(1H)-pyridinone compounds.
Public/Granted literature
- US2215181A Liquid distributor Public/Granted day:1940-09-17
Information query
IPC分类:
